Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma

Myxoid liposarcoma is a rare form of soft-tissue sarcoma. Although most patients initially respond well to treatment, approximately 21% relapse, highlighting the need for alternative treatments. To identify novel treatment regimens and gain a better understanding of myxoid liposarcoma tumor biology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerr, Lauren T., Donoghue, Jacqueline F., Wilding, Alexander L., Johns, Terrance G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086398/
https://www.ncbi.nlm.nih.gov/pubmed/27822137
http://dx.doi.org/10.1155/2016/3484673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086398/
https://www.ncbi.nlm.nih.gov/pubmed/27822137
http://dx.doi.org/10.1155/2016/3484673

Ejemplares similares